ARENA PHARMACEUTICALS INC's ticker is ARNAXXXX and the CUSIP is 040047102. A total of 129 filers reported holding ARENA PHARMACEUTICALS INC in Q1 2017. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2017 | $24,000 | +4.3% | 16,500 | 0.0% | 0.01% | +11.1% |
| Q4 2016 | $23,000 | -20.7% | 16,500 | 0.0% | 0.01% | -18.2% |
| Q3 2016 | $29,000 | +3.6% | 16,500 | 0.0% | 0.01% | +22.2% |
| Q2 2016 | $28,000 | -15.2% | 16,500 | 0.0% | 0.01% | -10.0% |
| Q1 2016 | $33,000 | +6.5% | 16,500 | 0.0% | 0.01% | +42.9% |
| Q4 2015 | $31,000 | – | 16,500 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Camber Capital Management LP | 10,500,000 | $17,955,000 | 0.87% |
| SENZAR ASSET MANAGEMENT, LLC | 1,872,191 | $3,201,447,000 | 0.70% |
| Virtus ETF Advisers LLC | 277,607 | $475,000 | 0.35% |
| GLOBEFLEX CAPITAL L P | 571,500 | $977,000 | 0.27% |
| Lyons Wealth Management, LLC. | 42,408 | $73,000 | 0.11% |
| TFS CAPITAL LLC | 222,736 | $381,000 | 0.07% |
| Jacobi Capital Management LLC | 35,000 | $56,000 | 0.03% |
| Renaissance Technologies | 5,601,355 | $9,578,000 | 0.02% |
| WELLINGTON MANAGEMENT GROUP LLP | 26,725,936 | $45,701,000 | 0.01% |
| PRELUDE CAPITAL MANAGEMENT, LLC | 46,300 | $79,000 | 0.01% |